Description
Developer of medical devices designed to treat patients with tinnitus and hearing loss disorder. The company's devices offer scientifically validated and reliable methods and metrics, enabling healthcare professionals to treat patients with tinnitus and hearing loss disorder to achieve better medical outcomes.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 01-Oct-2017 | 00000 | Completed | Out of Business | ||
2. Convertible Debt | 15-Oct-2014 | 00000 | 00000 | Completed | Generating Revenue | |
1. Early Stage VC | 19-Apr-2011 | $337K | $337K | Completed | Startup |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20140363007-A1 | Wearable device for relieving tinnitus, hyperacusis and/or hearing loss | Inactive | 14-Nov-2005 | 000000000 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Jeffrey DiGiovanni Ph.D | Founder, President & Chief Science Officer |
Name | Representing | Role | Since |
---|---|---|---|
Jeffrey Wiseman | Self | Board Member | 000 0000 |
Richard Giancola | Sanuthera | Chief Executive Officer & Board Member | 000 0000 |
Robert Dickey IV | Self | Board Member | 000 0000 |